Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro
Cancer cells, especially cancer stem cells (CSCs), are known for their therapeutic resistance and ability to induce a cancer relapse even many years after successful treatment. The quest for a novel protocol utilizing some commonly used non-oncologic drugs that would improve patients outcomes seems...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f238bb1d04a6494ca9f44fcad3067636 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f238bb1d04a6494ca9f44fcad3067636 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f238bb1d04a6494ca9f44fcad30676362021-11-11T15:05:36ZAspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro10.3390/app1121100092076-3417https://doaj.org/article/f238bb1d04a6494ca9f44fcad30676362021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3417/11/21/10009https://doaj.org/toc/2076-3417Cancer cells, especially cancer stem cells (CSCs), are known for their therapeutic resistance and ability to induce a cancer relapse even many years after successful treatment. The quest for a novel protocol utilizing some commonly used non-oncologic drugs that would improve patients outcomes seems to be the right solution. Aspirin (ASA) is one of such eminent drugs. Our study demonstrated that ASA may exert synergistic effect with the anti-Fas antibody on CSCs of colorectal cancer cell lines. We found that such compound treatment inhibited the pro-cancerous effect of anti-Fas stimulation and decreased spherogenicity, survival and CD133-positive cells’ count. Additionally, ASA with anti-Fas antibody may have a positive impact on dendritic cells’ functions. Our innovative study explored simultaneous usage of two biologically active compounds which haven’t been considered in such combination to assess their significance in colorectal cancer cell biology.Magdalena SzaryńskaAgata Olejniczak-KęderAdrian ZubrzyckiAnna WardowskaZbigniew KmiećMDPI AGarticlecancer stem cellscolorectal canceranti-Fasaspirindendritic cellsTechnologyTEngineering (General). Civil engineering (General)TA1-2040Biology (General)QH301-705.5PhysicsQC1-999ChemistryQD1-999ENApplied Sciences, Vol 11, Iss 10009, p 10009 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
cancer stem cells colorectal cancer anti-Fas aspirin dendritic cells Technology T Engineering (General). Civil engineering (General) TA1-2040 Biology (General) QH301-705.5 Physics QC1-999 Chemistry QD1-999 |
spellingShingle |
cancer stem cells colorectal cancer anti-Fas aspirin dendritic cells Technology T Engineering (General). Civil engineering (General) TA1-2040 Biology (General) QH301-705.5 Physics QC1-999 Chemistry QD1-999 Magdalena Szaryńska Agata Olejniczak-Kęder Adrian Zubrzycki Anna Wardowska Zbigniew Kmieć Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro |
description |
Cancer cells, especially cancer stem cells (CSCs), are known for their therapeutic resistance and ability to induce a cancer relapse even many years after successful treatment. The quest for a novel protocol utilizing some commonly used non-oncologic drugs that would improve patients outcomes seems to be the right solution. Aspirin (ASA) is one of such eminent drugs. Our study demonstrated that ASA may exert synergistic effect with the anti-Fas antibody on CSCs of colorectal cancer cell lines. We found that such compound treatment inhibited the pro-cancerous effect of anti-Fas stimulation and decreased spherogenicity, survival and CD133-positive cells’ count. Additionally, ASA with anti-Fas antibody may have a positive impact on dendritic cells’ functions. Our innovative study explored simultaneous usage of two biologically active compounds which haven’t been considered in such combination to assess their significance in colorectal cancer cell biology. |
format |
article |
author |
Magdalena Szaryńska Agata Olejniczak-Kęder Adrian Zubrzycki Anna Wardowska Zbigniew Kmieć |
author_facet |
Magdalena Szaryńska Agata Olejniczak-Kęder Adrian Zubrzycki Anna Wardowska Zbigniew Kmieć |
author_sort |
Magdalena Szaryńska |
title |
Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro |
title_short |
Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro |
title_full |
Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro |
title_fullStr |
Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro |
title_full_unstemmed |
Aspirin Exerts Synergistic Effect with Anti-Fas Stimulation against Colorectal Cancer Stem Cells In Vitro |
title_sort |
aspirin exerts synergistic effect with anti-fas stimulation against colorectal cancer stem cells in vitro |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/f238bb1d04a6494ca9f44fcad3067636 |
work_keys_str_mv |
AT magdalenaszarynska aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro AT agataolejniczakkeder aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro AT adrianzubrzycki aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro AT annawardowska aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro AT zbigniewkmiec aspirinexertssynergisticeffectwithantifasstimulationagainstcolorectalcancerstemcellsinvitro |
_version_ |
1718437187813376000 |